Humana Inc.
Humana Inc. (HUM) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · HUM · as of Jun 8, 2026
Key Statistics
Explore Humana Inc. Data
hum stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 44 · Buy rate: 31.8%
The HUM analyst consensus is Hold, based on ratings from 44 Wall Street analysts over the past 3 months. The average 12-month price target is $294.57, representing -15.86% downside from the current price of $350.08.
Competitors & Peers
hum competitorsHUM
A
ALC
CNC
GEHC
HLNStock Performance
Full HistoryAbout Humana Inc.
Humana Inc. together with its subsidiaries, operates as a health and well-being company in the United States. It operates through three segments: Retail, Group and Specialty, and Healthcare Services.…
what is humana inc. · hum stock overview · humana inc. company profile · who is humana inc. ceo · hum NYSE · humana inc. headquarters · humana inc. business segments
About Stock Overview & Key Data
Humana Inc. (HUM) is a Healthcare company in the Medical - Healthcare Plans industry, listed on NYSE since Dec 31, 1981. As of the latest trading session, HUM stock price is $350.08, with a market capitalization of $42.0B. The stock has returned +50.20% over the past 12 months and +36.68% year-to-date.
According to 44 Wall Street analysts, the consensus rating for Humana Inc. stock is Hold, with an average 12-month price target of $294.57. In fiscal year 2025, Humana Inc. reported revenue of $129.7B and net income of $1.2B. For detailed data — including Humana Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Humana Inc. (HUM) stock price is $350.08. The stock is traded on NYSE under the ticker symbol HUM. The 52-week range is $163.11 – $351.88.